View Author
protein antibody virus monkey vaccine clone class iscom preparation group challenge infection envelope response immunization serum antigen sivmac t cell clones animal protection study glycoprotein peptide measles assay osterhau presence macaque figure group b vaccination titre sequence class i immunodeficiency cytotoxic rhesu b-lcl t cells analysis ±iscom disease dilution ratio distemper elisa immunodeficiency virus fusion number 0.5 nature presentation morbilliviru class ii molecules mv-f-iscom sivmac 32h experiment outbreak mv ±iscom preparations culture semipuri ®ed quil epitope molecule immunity 8789- target rhesus macaques qa -3 control qa -22 table component method f-protein mv ±iscoms processing distemper virus puri ®ed quil siv infection
10 Most Recent Publications
|
In vivo antibody response and in vitro CTL activation induced by selected measles vaccine candidates, prepared with purified Quil A components.
(Article)
Stittelaar, K.J. Boes, J. Mulder, P.G.H. Spiekstra, A. Vries, P. de Roholl, P.J.M. Dalsgaard, K. Dobbelsteen, G.J.P.M. van den Alphen, L. van Osterhaus, A.D.M.E. Kersten, G.F.A. |
2000-05-01
|
|
Antigenicity and immunogenicity of recombinant envelope glycoproteins of SIVmac32H with different in vivo passage histories.
(Article)
Hulskotte, E.G.J. Rimmelzwaan, G.F. Boes, J. Bosch, M.L. Heeney, J.L. Norley, S.G. Vries, P. de Osterhaus, A.D.M.E. |
1995-01-01
|
|
Vaccine-induced virus-neutralizing antibodies and cytotoxic T cells do not protect macaques from experimental infection with simian immunodeficiency virus SIVmac32H (J5).
(Article)
Hulskotte, E.G.J. Geretti, A.M. Siebelink, C.H.J. Amerongen, G. van Cranage, M.P. Rud, E. Norley, S.G. Vries, P. de Osterhaus, A.D.M.E. |
1995-01-01
|
|
Protection of rhesus macaques from SIV infection by immunization with different experimental SIV vaccines.
(Article)
Vries, P. de Heeney, J.L. Morein, B. Norley, S. Osterhaus, A.D.M.E. Boes, J. Dings, M.E.M. Hulskotte, E.G.J. Dubbes, R. Koornstra, W. Haaft, P. ten Akerblom, L. Eriksson, S. |
1994-11-11
|
|
AIDS vaccine developments.
(Article)
Osterhaus, A.D.M.E. Vries, P. de Heeney, J. |
1992-01-01
|
|
Vaccination against acute respiratory virus infections and measles in man.
(Article)
Osterhaus, A.D.M.E. Vries, P. de |
1992-01-01
|
|
Comparison of protection from homologous cell-free vs cell-associated SIV challenge afforded by inactivated whole SIV vaccines.
(Article)
Heeney, J.L. Vries, P. de Dubbes, R. Koornstra, W. Niphuis, H. Haaft, P. ten Boes, J. Dings, M.E.M. Morein, B. Osterhaus, A.D.M.E. |
1992-01-01
|
|
Measles virus transmembrane fusion protein synthesized de novo or presented in iscom is endogenously processed for HLA class I- and class II-restricted cytotoxic T cell recognition.
(Article)
Binnendijk, R.S. van Baalen, C.A. van Poelen, M.C.M. Vries, P. de Boes, J. Cerundolo, V. Osterhaus, A.D.M.E. Uytdehaag, F.G.C.M. |
1992-01-01
|
|
Mass mortality in seals caused by a newly discovered morbillivirus.
(Article)
Osterhaus, A.D.M.E. Groen, J. Spijkers, H.E.M. Broeders, H.W.J. Uytdehaag, F.G.C.M. Vries, P. de Teppema, J.S. Visser, I.K.G. Bildt, M.W.G. van de Vedder, E.J. |
1990-09-24
|
|
Measles virus-specific murine T cell clones: characterization of fine specificity function.
(Article)
Vries, P. de Versteeg-van Oosten, J.P.M. Visser, I.K.G. Binnendijk, R.S. van Langeveld, S.A. Osterhaus, A.D.M.E. Uytdehaag, F.G.C.M. |
1989-04-15
|
